Sort   by:  
 Page size 
Snake venom is a rich source of peptides and proteins with a wide range of actions. Many of the components of the venom are currently being tested for their usefulness in the treatment of many diseases ranging from neurological and cardiovascular to cancer. It is also important to constantly search ...
ORGANISM(S): Vipera berus berus 
2016-12-12 | PXD004958 | Pride
The dynamic development of venomics in recent years has resulted in a significant increase in publicly available proteomic data. The information contained therein is often used for comparisons between different datasets and to draw biological conclusions therefrom. We aimed to show the possible diff...
ORGANISM(S): Naja ashei 
2020-09-07 | PXD020924 | Pride
In contrast to comprehensively investigated antibacterial activity of snake venoms, namely crude venoms and their selected components, little is known about antifungal properties of elapid snake venoms. In the present study, the proteome of two venoms of red spitting cobra Naja pallida (NPV) and Moz...
ORGANISM(S): Naja mossambica Naja pallida 
2020-08-12 | PXD020450 | Pride
Identification of protein composition of Naja ashei fractions obtained using IEX chromatography
ORGANISM(S): Naja ashei 
2020-01-21 | PXD015814 | Pride
The study aimed to fractionate Naja ashei venom with Size-exclusion chromatography to obtain fractions with significantly lower complexity than crude venom. MS analysis allowed to estimate the percentage of different protein groups in each fraction, thus providing information about the extent of hom...
ORGANISM(S): Naja ashei 
2021-09-10 | PXD023801 | Pride
The main objective of the project is to find the reason why antivenoms commonly used in treatments of Naja mossambica bites are not effective in Eswatini and Mozambique, whereas they exhibit normal activity in other countries of southern Africa. The main hypothesis here assumes that intra-species di...
ORGANISM(S): Naja mossambica 
2024-03-15 | PXD043722 | Pride
The main objective of the project is to find the reason why antivenoms commonly used in treatments of Naja mossambica bites are not effective in Eswatini and Mozambique, whereas they exhibit normal activity in other countries of southern Africa. The main hypothesis here assumes that intra-species di...
ORGANISM(S): Naja mossambica 
2024-03-15 | PXD043647 | Pride
Sort   by:  
 Page size